SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898430-01-000993
Filing Date
2001-03-22
Accepted
2001-03-22 00:00:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT #8 0001.txt SC 13D/A 8128
2 PURCHASE AGREEMENT DATED MARCH 19, 2001 0002.txt EX-7.11 144472
  Complete submission text file 0000898430-01-000993.txt   154757
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Subject) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-41938 | Film No.: 1575213
SIC: 2834 Pharmaceutical Preparations